Electrogel filtration: a combination of thin-layer gel filtration on Sephadex G 200 superfine and electrophoresis on cellulose acetate.
Explore the source record for details and available documents.
Blood Protein Electrophoresis↗
Biomedical subjects
R Stabilini
Publications and source records attributed to R Stabilini.
[Behavior of leucinaminopeptidase and gamma-glutamyltranspeptidase in the liver and spleen of rats exposed to total body irradiation].
Explore the source record for details and available documents.
Aminopeptidases↗
[Study of leucine aminopeptidase activity and its electrophoretic characteristics in the blood during pregnancy].
Explore the source record for details and available documents.
Adult↗
Prognostic value of serum gamma-glutamyl transpeptidase activity in liver disease.
Explore the source record for details and available documents.
Acyltransferases↗
Serum gamma-glutamyl transpeptidase activity in myocardial infarction.
Explore the source record for details and available documents.
Adult↗
Functional properties of glutaraldehyde cross-linked Hb in the presence of CO2 and/or inositolhexaphosphate (IHP).
Explore the source record for details and available documents.
Aerobiosis↗
[Carboxyhemoglobinemic levels and cardiovascular diseases].
Explore the source record for details and available documents.
Air Pollution↗
[Effect of total irradiation on certain enzymatic activities of blood serum, liver and gallbladder in rats. I. Lactate dehydrogenase. Quantitative determination and electrophoretic characterization].
Explore the source record for details and available documents.
Animals↗
[Effects of panirradiation on enzymatic activities of the serum, liver and spleen in rats. II. Alkaline phosphatase: quantitative determination and electrophoretic characterization].
Explore the source record for details and available documents.
Alkaline Phosphatase↗
Monitoring of extracorporeal membrane oxygenation with a PDP 8/e computer.
Explore the source record for details and available documents.
Animals↗
Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study.
BACKGROUND/AIMS: Tauroursodeoxycholic acid is a promising drug for the treatment of chronic cholestatic liver diseases since it has more favourable physicochemical and metabolic properties than ursodeoxycholic acid. Tauroursodeoxycholic acid may be of benefit also for necroinflammatory liver disease, especially for HCV-related chronic hepatitis in which bile duct damage and some degree of cholestasis are frequently seen at histology. METHODOLOGY: One hundred and fifty patients with chronic hepatitis were randomly assigned to receive tauroursodeoxycholic acid at daily doses of 500 mg or 750 mg, or a placebo for 6 months. RESULTS: A consistent decrease in aminotransferase serum levels was observed in patients treated with tauroursodeoxycholic acid compared with placebo (p<0.001) and a progressive improvement with time was also found (p<0.05; linear time effect). CONCLUSIONS: Tauroursodeoxycholic acid improves the biochemical expression of chronic hepatitis. Long-term studies with clinically relevant end-points are warranted.
Alanine Transaminase↗